Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

China

The first Affiliated Hospital of Xiamen University, Xiamen, Fujian

Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan

Henan Provincial People's Hospital, Zhengzhou, Henan

Qian Chu, Wuhan, Hubei

Hubei Cancer Hospital, Wuhan, Hubei